UBS Group AG Has $2.85 Million Stock Position in Transcat, Inc. (NASDAQ:TRNS)

UBS Group AG trimmed its position in Transcat, Inc. (NASDAQ:TRNS – Get Rating) by 1.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 37,614 shares of the scientific and technical instruments company’s stock after selling 422 shares during the period. UBS Group AG’s holdings in Transcat were worth $2,847,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in TRNS. Advisor Group Holdings Inc. boosted its holdings in shares of Transcat by 95.5% in the first quarter. Advisor Group Holdings Inc. now owns 5,107 shares of the scientific and technical instruments company’s stock worth $414,000 after buying an additional 2,495 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Transcat by 2.8% in the first quarter. Bank of New York Mellon Corp now owns 35,379 shares of the scientific and technical instruments company’s stock worth $2,871,000 after buying an additional 948 shares during the period. US Bancorp DE boosted its holdings in shares of Transcat by 137.9% in the first quarter. US Bancorp DE now owns 345 shares of the scientific and technical instruments company’s stock worth $28,000 after buying an additional 200 shares during the period. MetLife Investment Management LLC boosted its holdings in shares of Transcat by 41.3% in the first quarter. MetLife Investment Management LLC now owns 4,039 shares of the scientific and technical instruments company’s stock worth $328,000 after buying an additional 1,181 shares during the period. Finally, Rhumbline Advisers boosted its holdings in shares of Transcat by 16.1% during the first quarter. Rhumbline Advisers now owns 6,411 shares of the scientific and technical instruments company’s stock worth $520,000 after purchasing an additional 890 shares during the period. 83.24% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Transcat

In related news, Director Charles P. Hadeed sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 7th. The shares were sold at an average price of $87.07, for a total transaction of $174,140.00. Following the transaction, the director now owns 31,514 shares of the company’s stock, valued at $2,743,923.98. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 4.80% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on TRNS. Craig Hallum raised their price target on shares of Transcat from $81.00 to $92.00 and gave the stock a “buy” rating in a report on Wednesday, February 1st. Northland Securities raised their price target on shares of Transcat from $90.00 to $100.00 and gave the stock an “outperform” rating in a report on Wednesday, February 1st. Roth Capital raised their price target on shares of Transcat from $80.00 to $94.00 and gave the stock a “buy” rating in a report on Thursday, February 2nd. Finally, HC Wainwright raised their price target on shares of Transcat from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 1st. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.50.

Transcat Price Performance

Shares of TRNS opened at $91.45 on Friday. The firm has a market cap of $691.36 million, a PE ratio of 69.28 and a beta of 0.78. The firm’s 50 day moving average price is $82.45 and its 200 day moving average price is $78.20. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.75 and a current ratio of 2.42. Transcat, Inc. has a twelve month low of $50.32 and a twelve month high of $91.71.

Transcat (NASDAQ:TRNS – Get Rating) last issued its quarterly earnings data on Monday, January 30th. The scientific and technical instruments company reported $0.21 earnings per share for the quarter, meeting the consensus estimate of $0.21. The firm had revenue of $57.40 million for the quarter, compared to analyst estimates of $56.62 million. Transcat had a net margin of 4.49% and a return on equity of 12.30%. As a group, research analysts expect that Transcat, Inc. will post 1.33 EPS for the current fiscal year.

About Transcat

(Get Rating)

Transcat, Inc engages in provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation.